Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Search Posts
Op-Eds
Much Ado About Nothing?
The last year has been a bad one for future AIDS victims. The U.N. AIDS conference in Barcelona was an activist circus. U.S. Secretary…
News Release
Senate Vote a Setback for Public Health
<?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” />Washington, D.C., July 24, 2003—The U.S. Senate yesterday approved a measure that would allow the Food…
Op-Eds
West Nile Virus: A Public Health Crisis?
Full article available in pdf format Public health officials can only hope that this summer doesn't see a repeat of last year's…
Roll Call
Fireworks Fly
Op-Eds
Recent Research Suggests…
There has been a great deal of ballyhoo this week over the decision by the U.S. Food and Drug Administration to require food products…
News Release
Pharmaceutical Re-Imports Threaten Medical Innovation
Contact for Interviews: Richard Morrison, 202.331.2273 Washington, D.C., July 18, 2003—The Competitive Enterprise Institute is opposing proposals to allow the re-importation of drugs from foreign…